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Dinoflagellates in the genus Pfiesteria were
first identified in the early 1990s by JoAnn
Burkholder and colleagues at North
Carolina State University, Raleigh, North
Carolina, in association with ﬁsh kills in the
Pamlico and Neuse estuaries in North
Carolina (1). These studies further suggested
that exposure to toxic forms of the organism
contributed to the appearance of characteris-
tic “punched out” skin lesions in fish (1,2)
[an assumption that has been the source of
some recent controversy (3)].
Shortly after the initial description of
Pfiesteria, questions were raised about the
human health impact of contact with the
organism and its toxin(s). Laboratory person-
nel working with Pfiesteria became ill (4,5),
and there were subsequent reports of illness
associated with environmental exposure to
waterways where the dinoflagellate was pre-
sent (4,6). Although questions remain about
the linkage between Pfiesteria and the
observed clinical syndromes, there are sugges-
tions that chronic or recurrent high-level
exposure to Pﬁesteria and its toxin (i.e., expo-
sure to Pﬁesteria at a time when there is evi-
dence of toxin production, as manifested by
ﬁsh kills and/or a high frequency of ﬁsh with
skin lesions) produces a distinctive clinical
syndrome characterized by difficulties in
learning and memory. More transient mani-
festations (confusion, ﬂulike symptoms) have
been reported in association with a single
intense exposure (7). 
This article provides a synthesis of these
and other available clinical data, with a focus
on studies conducted by investigators who
were part of the joint University of
Maryland/Johns Hopkins University
research group on Pfiesteria. Given the
recent recognition of this clinical entity, its
apparent rarity, and the lack of a definitive
diagnostic test for exposure, data have, of neces-
sity, been drawn from multiple sources, includ-
ing peer-reviewed articles, conference
presentations, abstracts, and newspaper reports.
Clinical Syndromes Associated
with Pﬁesteria
Chronic/Recurrent High-Level Exposure
North Carolina: laboratory exposure. The
first indication that toxins produced by
Pfiesteria could cause human illness came
when investigators working with the organ-
ism in Burkholder’s laboratory in North
Carolina began to experience problems with
respiratory and eye irritation, skin rashes, gas-
troenteritis (stomach cramps, nausea, vomit-
ing) and of particular concern, cognition and
personality changes. These data were initially
reported by Glasgow et al. (4); a more
detailed report of neurologic and neurocogni-
tive findings from one of the most severely
affected individuals has recently been pre-
sented (5). Although most symptoms appear
to have resolved, concerns remain among
affected investigators about persistent effects
(including persistent neurocognitive deﬁcits)
7–8 years after the acute incident.
The exposures in these cases appear to
have been both high level (exposure to water
from tanks containing Pﬁesteria showing evi-
dence of toxin production) and recurrent
(occurring repeatedly during a period of 2–3
months). It was postulated that exposure was
due both to direct water contact and inhala-
tion of aerosols from toxic tanks. The level of
exposure for some investigators may have
been increased by a construction error that
resulted in venting of air from the room
where toxic cultures were being prepared into
an ofﬁce area. 
Maryland: Pocomoke River. In the fall of
1996, Maryland commercial fishermen
(watermen) working along the Pocomoke and
other small rivers emptying into Tangier
Sound on the eastern shore of the Chesapeake
Bay (Figure 1) began to note increasing prob-
lems with fatigue, headaches, respiratory irri-
tation, and memory disturbances. Persons
who were most severely affected worked pri-
marily on the Pocomoke River, often with ≥6
hr of water exposure per day, 6 days/week,
extending over several months. Some were
bank trappers who collected fish from traps
set up near the bank of the river; these per-
sons reported that, at times, 70–80% of the
fish collected from the traps were moribund
or had “punched out” skin lesions. 
Using light and scanning electron
microscopy, Burkholder and colleagues from
North Carolina State University identified
Pfiesteria [Pfiesteria piscicida Steidinger &
Burkholder and other Pfiesteria-like species
(1)] in water samples collected from the
Pocomoke River during the summer of
1997. After ﬁsh kills occurred on the river in
August 1997, the Maryland Department of
Health and Mental Hygiene asked investiga-
tors at the University of Maryland and Johns
Hopkins to evaluate health complaints
among watermen. Ultimately, 24 case per-
sons were evaluated. All had direct contact
with the Pocomoke River and/or other estu-
arine waters of the Chesapeake Bay during
periods of fish kills or at times when a high
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percentage of fish had skin lesions (6). This
included seven of the eight watermen who
regularly worked on the Pocomoke River,
state employees having contact with the river
as a result of ofﬁcial duties, and persons with
recreational water contact. Exposed persons
were divided by degree of exposure [severe,
contact with affected waterways 6–8 hr/day
on an almost daily basis; moderate, 8–20 hr/
week assessing fish or collecting water sam-
ples from affected waterways (including, in
some cases, minimal water contact, but fre-
quent exposures to water aerosols while
scooping up dead fish); low, little or no
direct skin contact with water but had ridden
in boats on the Pocomoke during fish kill
events]. Controls were selected for each case
person, matching on age, sex, occupation,
and educational level. Watermen controls
were selected from among watermen working
on the ocean side of the Delmarva peninsula,
where lesioned ﬁsh had not been seen.
Physical examination and clinical labora-
tory studies of exposed persons were generally
unremarkable (6). Persons with severe levels
of exposure were significantly more likely
than controls to complain of neuropyscholog-
ical problems (confusion, episodes of disori-
entation, new or increased forgetfulness, or
difficulties concentrating; 82 vs 13%, p <
0.01), headaches (82 vs 13%, p < 0.01), and
skin lesions (73 vs 13%, p < 0.05). Skin
lesions were reported as erythematous, ede-
matous papules on the trunk or extremities
(8) and generally resolved within a few days
to a week. On careful dermatologic evalua-
tion, lesions appeared to have a variety of eti-
ologies. However, on skin biopsy there was a
subset of lesions (from 4 of 12 patients) that
had similar histopathologic ﬁndings, sugges-
tive of an inflammatory, toxic, or allergic
process (8,9); these same four patients had
the most severe neurocognitive changes, as
described below (p < 0.01) (9). 
Significant associations were found
between the degree of exposure to Pﬁesteria-
affected Maryland waterways and deﬁciencies
in learning, memory, and higher-order cogni-
tive function, as measured by formal neu-
rocognitive testing [see Grattan et al. (6) for a
complete description of tests and analysis of
results]. Results were most striking on the
Rey Auditory Verbal Learning and Memory
Test (Rey AVLT), which measures the ability
of persons to remember word lists at succes-
sive time points. As shown in Table 1, there
was a signiﬁcant difference between the four
exposure groups with respect to performance
on trial 5 of the Rey AVLT, with the degree
of deficit corresponding to degree of expo-
sure. The primary deficit appeared to be in
the ability of patients to place new observa-
tions into memory (i.e., to learn). In contrast,
material that had already been learned could
generally be recalled without difﬁculty.
Patients in this study tended to be
young, male, self-employed, and otherwise
healthy; on tests of mood state, most ranked
as vigorous. Findings were not consistent
with a hysterical reaction (10), and persons
with any suggestion of malingering or
symptom exaggeration or who had any
other possible explanation for the observed
deficits were excluded from analysis. When
patients (and controls) were formally
retested 3 and 6 months after cessation of
exposure, patient test scores increased sig-
nificantly, returning in all instances to a
normal range (6). Although deficits in most
instances appear to have resolved com-
pletely, some patients continue to feel that
they are not “back to normal.” 
Virginia: Pocomoke River. The Pocomoke
River lies on the border between Maryland
and Virginia on the Delmarva peninsula.
Using test batteries similar to those employed
in Maryland, investigators working with the
Virginia health department tested four
persons. Two of the four persons (both of
whom had “extensive, daily exposure” to the
Pocomoke River during the summer of 1997)
were reported to show evidence of mild to
moderate short-term memory loss and prob-
lems with focusing their attention. Both also
had abnormalities on magnetic resonance
imaging scans; researchers felt these abnormal-
ities did not explain the observed deﬁcits (11).
Possible Acute High-Level Exposure
Maryland: Chicamacomico River. Six of
seven state employees sent to investigate a
ﬁsh-distress/kill event on the Chicamacomico
River (a river close to the Pocomoke that also
empties into Tangier Sound on the Maryland
Eastern Shore) reported acute respiratory and
eye irritation, headache, and/or sore throat
within 4 hr of exposure to the river (7). None
of these persons were included in the
Pocomoke River study described above. Three
of the affected persons had direct water con-
tact, whereas for the other four, contact was
primarily from aerosols coming off the river.
The weather was described as warm (80°F),
humid (100%), and windless, with workers
reporting a heavy mist rising off the slow-
moving water. During the event, four devel-
oped burning eyes or nares, and six developed
a headache or sore throat. Six developed
crampy abdominal pain, nausea, or diarrhea
within 4 hr of their exposure. However, when
formal neuropsychological testing was done
within 3 weeks of the event (and again 3
months later) no consistent pattern of deﬁcit
was seen. Symptoms generally resolved within
a week. Skin lesions were not reported.
The fish-distress/kill event was localized
to a length of the river of approximately 600
yards; at its height, an estimated 75,000–
450,000 Atlantic menhaden were distressed,
with virtually 100% of ﬁsh sampled showing
skin lesions. A water sample collected at the
time had a dissolved oxygen value of 7.7
mg/L and a pH of 7.1. P. piscicida was pre-
sent in water samples collected during the
acute event, based on scanning electron
microscopic studies conducted by K.
Steidinger; samples were also toxic in fish
assays conducted by J. Burkholder (7). 
North Carolina/Maryland: case reports.
There are case reports from both North
Carolina (4) and Maryland (12,13) suggest-
ing an association between exposure to
waterways known to have Pfiesteria activity
and the appearance of one or more of a com-
bination of symptoms, including skin
lesions, headache, gastrointestinal symptoms,
eye and respiratory irritation, and mental
confusion. Although documentation is not
always optimal, symptoms generally appear
to have resolved within a week or so of the
acute exposure.  Figure 1. Chesapeake Bay Region.
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Table 1. Means, standard deviations, and ANOVA for
Scores on two experimental neuropsychological mea-
sures for case persons and controls, Pocomoke River
study in Maryland.a
Mean (SD) Mean (SD) 
Rey AVLT  Stroop
trial 5 Interference
Number T scoreb T scorec
Exposure
None 19 54.21 (7.32) 51.58 (7.99)
Mild 3 35.33 (14.74) 39.00 (2.00)
Moderate 7 38.57 (13.15) 48.83 (11.36)
Severe 9 19.56 (16.69) 39.78 (10.87)
Results
ANOVA p < 0.0001 p < 0.0001
Linear trend p = 0.011 p = 0.006
ANOVA, analysis of variance. 
aData from Grattan et al. (6). bRey AVLT measures the capacity
for new verbal learning and memory for complex verbal informa-
tion. cStroop interference test, from Stroop Color-Word Test;
assesses resistance to interference and selective attention.Human health effects and Pﬁesteria exposure
Chronic Low-Level Exposure
There are now increasing data that support
the concept that P. piscicida and other
Pﬁesteria species are relatively widely distrib-
uted in the estuarine environment. For exam-
ple, in studies conducted in Maryland by
Oldach and colleagues, employing a real-time
PCR assay for P. piscicida, the organism was
detected at multiple estuarine sites in
Chesapeake Bay (14). Detection was most
common in late summer and at sites with
higher nutrient and phytoplankton biomass.
The potential for toxicity among these iso-
lates remains controversial (2). Nonetheless,
the presence of the organism at multiple sites
raises questions about possible human health
effects of low-level exposure [exposure to the
organism in a setting in which there is no or
minimal toxin production (as reﬂected by the
lack of major ﬁsh kills or minimal numbers of
lesioned ﬁsh) and/or very limited exposure to
waterways in which there is evidence of toxic
Pﬁesteria activity].
Grifﬁn and colleagues, in a 1996 study in
North Carolina, compared reported symp-
toms among two groups of crabbers (those
working in and those working outside of
waters where ﬁsh kills in which Pﬁesteria has
been implicated as a cause are known to have
occurred) and a third group of nonfishing
individuals (15). For most conditions, sub-
jects in all three groups reported comparable
levels of injury and illness. Fatigue was more
commonly reported by crabbers working in
ﬁsh-kill areas than in areas without ﬁsh kills
(9.4 vs 3.5%, p = 0.05); however, this was felt
to be attributable to the participants’ percep-
tions of “overwork” or the presence of other
underlying medical conditions rather than
water quality. The ratio of well to ill crabbers
was slightly lower for crabbers working in the
two areas known to have experienced fish
kills. These studies were based on self-
reported symptoms and did not include
formal neuropsychological testing. 
Formal testing was included in a subse-
quent North Carolina study looking at smaller
groups of watermen working in waterways
where diseased or stressed ﬁsh were reported
from June to September 1997, and where
Pfiesteria has been reported in the past
(n = 22), and controls from unaffected water-
ways (n = 21). Testing in this study was per-
formed 3 months after the last documented
ﬁsh kill in affected waters. No differences were
found among groups, with one exception:
Persons with exposures to affected waterways
had signiﬁcant deﬁciencies in visual contrast
sensitivity, an indicator of impairment in
human visual-system function. Findings are
similar to those reported among organic
solvent-exposed workers; however, cases
(exposed persons) and controls in this study
did not differ in their history of exposure to
such compounds (16,17). These ﬁndings have
led Shoemaker and Hudnell to propose adop-
tion of visual contrast sensitivity (as measured
by the Functional Acuity Contrast Test) as the
key diagnostic test for Pﬁesteria syndrome (13).
Summary and Discussion
The strongest data for a link between
Pﬁesteria and its toxins and human illness are
those associated with the laboratory exposures
in the Burkholder laboratory. The Pocomoke
River studies (and the concurrent, albeit
much more limited, Virginia studies) identi-
ﬁed a group of patients with a distinctive clin-
ical syndrome, characterized by difficulties
with learning and memory, in an environ-
mental setting in which Pﬁesteria was known
to be present. The data from these latter
studies are not sufﬁcient to say that Pﬁesteria
or Pfiesteria toxin were the immediate cause
of the observed illness, and there remain
questions about the possible contribution to
illness of other toxic algal species that may
have been present. Nonetheless, it is a plausi-
ble hypothesis, given the similarities in neuro-
cognitive symptoms seen among laboratory-
and environmentally exposed persons, and
the work by Levin demonstrating learning
problems in rats exposed to toxic material
from Pfiesteria (18–20). These observations
further suggest that development of learning
and memory problems (if due to Pfiesteria)
requires recurrent, presumably high-level
exposure. Symptoms appear to resolve within
3–6 months of exposure (6), although con-
cerns remain about long-term sequelle in
severely affected persons. At a much more
anecdotal level, there are suggestions that an
episode of intense exposure to waterways in
which toxic Pﬁesteria is present can result in
an acute syndrome characterized by eye and
respiratory irritation, headache, fatigue,
and/or gastrointestinal symptoms (7).
As noted above, some investigators have
proposed reliance on visual contrast sensitiv-
ity as the basis for diagnosing Pfiesteria syn-
drome (13). Data supporting use of the test
in this setting are weak. Visual contrast sensi-
tivity is affected by underlying eye disorders,
including corneal and lens disorders (i.e., the
effect on the contrast sensitivity function is
optical), as well as retinal and optic nerve dis-
orders. As the individuals most likely to expe-
rience possible Pfiesteria toxin exposure are
those individuals spending significant
amounts of time on the water, there is a
heightened probability of ultraviolet expo-
sure-associated eye disease, such as lenticular
opacity and age-related macular degeneration.
Thus, a positive screening test for impaired
contrast sensitivity may simply reflect the
environmental/occupational context for the
tested individual. There is clearly a need for
further research in this area.
The physiologic mechanisms underlying
the observed memory and learning deficits
remain obscure. Recent work by investigators
at the University of Maryland has raised the
possibility that bioactive material from
Pfiesteria acts as an N-methyl-D-aspartate
(NMDA) neurotransmitter receptor antago-
nist (21). The NMDA receptor plays a criti-
cal role in neural plasticity and learning
(22,23); the observed learning and memory
deﬁcits in patients could plausibly be attrib-
uted to a toxin having this type of biologic
activity. In terms of route of exposure, it is
possible that the toxin/toxic material is trans-
mitted by aerosols. By analogy, aerosolization
of toxin/toxic material has been implicated as
the cause of respiratory irritation reported in
association with exposure to Gymnodinium
breve red tides on the east coast of Florida
(24). Skin contact with water and/or affected
fish may also be a risk factor. In contrast,
consumption of ﬁsh or shellﬁsh has not been
implicated as a cause of the described ill-
nesses (25). Maryland and other mid-
Atlantic states have developed policies for
closure of waterways when the organism
appears to be present and active, as mani-
fested by ﬁsh kills or signs of toxicity in ﬁsh.
Until there is a better understanding of
Pfiesteria toxins and their mode of action, it
would appear prudent for persons who must
come in contact with such waterways, partic-
ularly in the midst of an active Pfiesteria-
related fish kill, to wear protective clothing
and respiratory protective gear. 
Intense surveillance conducted since
1997 in Maryland and other mid-Atlantic
states suggests that the clinical syndrome
described in association with intense, high-
level exposures to toxic Pfiesteria, as seen in
the Burkholder laboratory and along the
Pocomoke River, is rare. The North Carolina
crabber study (15) further suggests that rou-
tine occupational (and recreational) exposure
to waterways where Pﬁesteria is known to be
present has minimal health effects, at least at
a subjective level. From a public health
standpoint (and in light of the previously
noted relatively wide distribution of Pﬁesteria
in the environment) the key question would
appear to be whether there is any cumulative
effect resulting from chronic, low-level expo-
sure to the organism and its toxin in the
environment. The cohort studies currently
under way in Maryland, Virginia, and North
Carolina, sponsored by state health depart-
ments and the Centers for Disease Control
and Prevention, may help to address this
critical question.
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